{"mainPropery":{"diseaseId":12351,"diseaseName":"BRCA1 hereditary breast and ovarian cancer syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12351/brca1-hereditary-breast-and-ovarian-cancer-syndrome","synonyms":["BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED","OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED","Familial susceptibility to breast-ovarian cancer 1","BROVCA1"],"synonyms-with-source":[{"name":"BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED","source":"OMIM"},{"name":"OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED","source":"OMIM"},{"name":"Familial susceptibility to breast-ovarian cancer 1","source":"OMIM"},{"name":"BROVCA1","source":"MedGen"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"145"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":10,"diseaseTypeName":"Female Reproductive Diseases","source":"Orphanet"},{"diseaseTypeId":28,"diseaseTypeName":"Hereditary Cancer Syndromes"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":120,"resourceName":"American Cancer Society","abbreviation":"","address1":"250 Williams Street NW","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30329","country":"United States","phone":"","tty":"","tollFree":"1-800-227-2345","fax":"","email":"","url":"https://www.cancer.org","freeText":""},{"resourceID":319,"resourceName":"Ovarian Cancer Research Alliance","abbreviation":"","address1":"14 Pennsylvania Plaza, Suite 2110","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10122","country":"United States","phone":"212-268-1002","tty":"","tollFree":"866-399-6262","fax":"202-331-2292","email":"info@ocrahope.org","url":"https://ocrahope.org","freeText":""},{"resourceID":320,"resourceName":"National Ovarian Cancer Coalition","address1":"2501 Oak Lawn Avenue, Suite 435","address2":"","address3":"","address4":"","address5":"","city":"Dallas","state":"TX","zip":"75219 ","country":"United States","phone":"214-273-4200 ","tty":"","tollFree":"888-OVARIAN","fax":"214-273-4201 ","email":"nocc@ovarian.org","url":"http://www.ovarian.org/"},{"resourceID":468,"resourceName":"The National Breast Cancer Coalition/Fund","address1":"1101 17th Street Northwest","address2":"Suite 1300","address3":"","address4":"","address5":"","city":"Washington","state":"DC","zip":"20036 ","country":"United States","phone":"202-296-7477 ","tty":"","tollFree":"800-622-2838","fax":"202-265-6854 ","email":"","url":"http://www.stopbreastcancer.org/"},{"resourceID":470,"resourceName":"The Susan G. Komen Breast Cancer Foundation","abbreviation":"","address1":"5005 LBJ Freeway","address2":"Suite 250","address3":"","address4":"","address5":"","city":"Dallas","state":"TX","zip":"75244","country":"United States","phone":"972-855-1600","tty":"","tollFree":"877-465-6636","fax":"972-855-1605","email":"helpline@komen.org","url":"http://ww5.komen.org/"},{"resourceID":2513,"resourceName":"FORCE: Facing Our Risk of Cancer Empowered","abbreviation":"","address1":"16057 Tampa Palms Blvd. W, PMB #373","address2":"","address3":"","address4":"","address5":"","city":"Tampa","state":"FL","zip":"33647","country":"","phone":"","tty":"","tollFree":"866-288-RISK (7475)","fax":"954-827-2200","email":"info@facingourrisk.org","url":"http://www.facingourrisk.org"},{"resourceID":2965,"resourceName":"Bright Pink","abbreviation":"","address1":"670 N. Clark St., Suite 2","address2":"","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60654","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"http://www.brightpink.org"},{"resourceID":3366,"resourceName":"Minnesota Ovarian Cancer Alliance","abbreviation":"","address1":"4604 Chicago Ave ","address2":"","address3":"","address4":"","address5":"","city":"Minneapolis","state":"MN","zip":"55407","country":"","phone":"612-822-0500","tty":"","tollFree":"","fax":"","email":"INFO@MNOVARIAN.ORG","url":"http://mnovarian.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=BRCA1+%5BTitle%5D+AND+Hereditary+Breast+and+Ovarian+Cancer' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss BRCA1 hereditary breast and ovarian cancer syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://clinicaltrials.gov/ct2/results?term=BRCA1&no_unk=Y' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to BRCA1 hereditary breast and ovarian cancer syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/breast-cancer' target='_blank'>Genetics Home Reference (GHR)</a> contains information on BRCA1 hereditary breast and ovarian cancer syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0677776/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=145' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1247/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The National Cancer Institute provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n<a href='http://www.cancer.gov/cancertopics/genetics/brca-fact-sheet' target='_blank'>BRCA1 and BRCA2: Cancer Risk and Genetic Testing</a><br /><a href='http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional' target='_blank'>Genetics of Breast and Gynecologic Cancers (PDQÂ®)</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1548,"resourceId":2176,"resourceName":"Centers for Disease Control and Prevention","descriptionText":"You can obtain information on this topic from the <a href='http://www.cdc.gov/Features/HereditaryCancer/' target='_blank'>Centers for Disease Control and Prevention</a> (CDC). The CDC is recognized as the lead federal agency for developing and applying disease prevention and control, environmental health, and health promotion and education activities designed to improve the health of the people of the United States.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1792,"resourceId":2964,"resourceName":"MD Anderson","descriptionText":"<a href='http://www.mdanderson.org/education-and-research/resources-for-professionals/professional-educational-resources/professional-oncology-education/hboc/index.html' target='_blank'>MD Anderson Cancer Center</a>&nbsp;offers a free online course on BRCA1 hereditary breast and ovarian cancer syndrome. Click on the link to access this course.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:604370' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":8415,"questionText":"What is <em>BRCA1</em> hereditary breast and ovarian cancer syndrome?","answerText":"<em><strong>BRCA1</strong></em><strong> hereditary breast and ovarian cancer syndrome (<em>BRCA1</em> HBOC) </strong>is an inherited condition that is characterized by an increased risk for a variety of different cancers. Women with this condition have a 57-60% risk of developing breast cancer, a 40-59% risk of developing ovarian cancer and an 83% risk of developing <a href=\"http://www.cancer.gov/dictionary?cdrid=44169\" target=\"_blank\">contralateral</a> breast cancer by age 70. Men have a 1% lifetime risk of breast cancer and an increased risk for prostate cancer. <em>BRCA1</em> HBOC  may also be associated with an elevated risk for cancers of the cervix, uterus, pancreas, esophagus, stomach, fallopian tube, and primary peritoneum; however, these risks are not well defined.[8477][8479] This condition is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/BRCA1\" target=\"_blank\"><em>BRCA1</em></a> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner.[8480] Management may include high risk cancer screening, <a href=\"http://www.cancer.gov/dictionary?cdrid=45487\" target=\"_blank\">chemoprevention</a>&nbsp;and/or <a href=\"http://www.cancer.gov/dictionary?CdrID=256574\" target=\"_blank\">prophylactic</a> surgeries.[8477][8481]","dateModified":"2015-03-10T10:53:00"},"basicQuestions":[],"references":[{"referenceId":8278,"authors":"","articleTitle":"Breast-ovarian cancer, familial 1(BROVCA1)","bookWebsiteJournalTitle":"MedGen","date":"","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/medgen/?term=BREAST-OVARIAN+CANCER%2C+FAMILIAL%2C+SUSCEPTIBILITY+TO%2C+1%3B+BROVCA1","dateAccessed":"2015-02-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8279,"authors":"","articleTitle":"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1","bookWebsiteJournalTitle":"OMIM","date":"02/21/2014","volume":"","pages":"","url":"http://omim.org/entry/604370?search=hereditary%20breast-ovarian%20cancer&highlight=breastovarian%20cancerous%20cancer%20hereditary","dateAccessed":"2015-02-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8280,"authors":"Petrucelli N, Daly MB & Feldman GL","articleTitle":"BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer","bookWebsiteJournalTitle":"GeneReviews","date":"September 26, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1247/","dateAccessed":"2015-02-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":664,"dateCreated":"2019-08-27T11:11:00","publishDate":"2019-08-27T00:00:00","title":"Should I Be Tested for BRCA Mutations?","description":"The US&nbsp;Preventive Services Task Force (USPSTF) recently published recommendations on risk assessment, genetic counseling, and genetic testing for BRCA mutations and BRCA-related cancers. This JAMA Patient Page explain the new recommendations.&nbsp;<br />\r\n<br />\r\nJin J.&nbsp;Should I Be Tested for BRCA Mutations?&nbsp;JAMA. 2019;322(7):702.&nbsp;","url":"https://jamanetwork.com/journals/jama/fullarticle/2748510","lastModified":"2019-08-27T11:11:00","isFeatured":false},{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14099,"phenoTypeName":"Abnormal fallopian tube morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6959,"phenoTypeName":"Ovarian neoplasm","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":2308,"phenoTypeName":"Primary peritoneal carcinoma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8875,"phenoTypeName":"Breast carcinoma","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7951,"phenoTypeName":"Melanoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4303,"phenoTypeName":"Neoplasm of the pancreas","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2730,"phenoTypeName":"Prostate cancer","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[{"productId":616,"genericName":"Olaparib","tradeName":"Lynparza","tradeLink":"http://www.lynparza.com/","manufacturer":"","sponsor":"AstraZeneca Pharmaceuticals LP","indication":"December 2018, olaparib (Lynparza) received expanded approval for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum based chemotherapy. Select patients with gBRCAm advanced epithelial ovarian, fallopian tube or primary peritoneal cancer for therapy based on FDA-approved companion diagnostic for Lynparza. Original approval was in August 2017.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/lynparza","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a614060.html"},{"productId":658,"genericName":"Rucaparib","tradeName":"Rubraca","tradeLink":"https://www.rubraca.com/","manufacturer":"","sponsor":"Clovis Oncology, Inc.","indication":"December 2016 approved as monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/rubraca","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a617002.html"}],"EncodedName":"BRCA1_hereditary_breast_and_ovarian_cancer_syndrome"}